biospaceJanuary 29, 2018
Tag: Celgene , Neurosciences
Two years ago during a lunch with a group of reporters at the J.P. Morgan confab, then Celgene CEO (now executive chairman) Bob Hugin got my attention with a comment on the importance of neurosciences in the pipeline.
Any company that expects to have a major position in the industry a decade from now will almost have to play a big role in developing therapies for neurodegeneration, he told us, making it clear that he wasn’t talking about some sudden splurge on neurodegeneration deals.
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us: